Trial Profile

A randomized Phase 1 placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics and food effect of BMB-105 in healthy volunteers

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 16 Jan 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

06 Jan 2026 According to Bright Minds Biosciences media release, the company intends to use the net proceeds from the Offering of aggregate gross proceeds of USD100 million to fund initiation of phase 1 clinical drug trials for BMB-105.
09 Dec 2025 New trial record
06 Nov 2025 According to Bright Minds Biosciences media release, the company announced that the initiation of its Prader-Willi Syndrome (PWS) program. As part of the development program, Bright Minds will commence this study.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com